Chengdu Kaijie Biopharm Co. Ltd. (KJBP) is one of the leading peptide manufacturers in China. It was founded in Chengdu in March, 2003 by a team of experienced peptide chemists with a combined industrial experience over 20 years.


KJBP has oriented its business along two main lines:the investigation,development,production and commercialization of generic bulk peptide APIs for the international markets,and custom synthesis service for buliding blocks,amino acid resin and peptide sequences which meet researchers' specific demand worldwide.


Dayi campus in the suburb of Chengdu city provides KJBP with a good infrastructure for both industrial-scale production of peptides and Custom Synthesis.The pharmaceutical grade solid phase peptide synthesis in Dayi campus can meet USP, EP or the requirements of CP, single batches are up to Kg scales.
  

KJBP has begun to implement the 2008 development plan which is improving quality management standards and increasing production scale.Currently Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled